Bahar Nayeri Fasaei
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Bahar Nayeri Fasaei has a total of 70 co-authors. Here are the top co-authors by number of shared publications:
Hesameddin Akbarein
Department of Food Hygiene and Quality Control, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran
4 shared publications- Aghil Sharifzadeh
Department of Microbiology and Immunology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran
3 shared publications Aram Sharifi
Department of Animal Science, Faculty of Agriculture, University of Kurdistan, Sanandaj, Iran
3 shared publicationsSepideh Asadi
Department of Microbiology and Immunology, Faculty of Veterinary Medicine University of Tehran Tehran Iran
3 shared publicationsAlireza Bahonar
Department of Food Hygiene, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran
2 shared publicationsI Ashrafi Tamai
Department of Microbiology and Immunology , Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran
2 shared publications
Latest Publications
- Open Access
- 22 October 2026
- Published by Springer Nature in BMC Veterinary Research
Phylogenetic typing of Escherichia coli isolated from goat kids with Hemorrhagic Abomasitis and associated clinical findings
- 22 October 2026
- Published by Springer Nature in BMC Veterinary Research
Open AccessPhylogenetic typing of Escherichia coli isolated from goat kids with Hemorrhagic Abomasitis and associated clinical findings
- 17 September 2026
- Published by Springer Nature in BioNanoScience
- Vol. 16 (10) , 629
Antifungal Activity and Binding Potential of Nanoencapsulated Propolis Against Key Cell Wall and Plasma Membrane Biosynthetic Enzymes in Resistant Candida albicans
- 17 September 2026
- Published by Springer Nature in BioNanoScience
- Vol. 16 (10) , 629
Antifungal Activity and Binding Potential of Nanoencapsulated Propolis Against Key Cell Wall and Plasma Membrane Biosynthetic Enzymes in Resistant Candida albicans
- Open Access
- 1 October 2025
- Published by Negah Scientific Publisher in Iranian Journal of Veterinary Medicine
- Vol. 19 (4) , 677-684
Detection of Campylobacter spp. in Healthy Pet Rabbits and Rodents Using Multiplex Polymerase Chain Reaction
Background: Campylobacter is a common cause of human gastroenteritis. These species can cause diarrhea, hematochezia, meningitis, septicemia and Guillain-Barre syndrome. Objectives: This study aims to determine the prevalence of Campylobacter spp. in healthy pet rabbits, guinea pigs, hamsters and squirrels referred to Small Animal Teaching Hospital, Faculty of Veterinary Medicine, University of Tehran. Food-producing animals are vital sources of infection in humans. While rabbit and guinea pig meat and fur consumption have increased in many countries, little is known about their role as a source of infection. Therefore, the true incidence of Campylobacter infections may be underestimated. Methods: Fecal samples from 92 rabbits, four guinea pigs, two hamsters and two squirrels were acquired and assessed for Campylobacter species by culture and multiplex polymerase chain reaction (PCR). Statistical analysis was performed using the SPSS software, version 26. Chi-square and Fisher’s exact tests were used to analyze qualitative data. Results: Five samples from rabbits, one sample from hamsters, and one sample from squirrels were positive for Campylobacter spp. No Campylobacter spp. were detected in guinea pigs. All the species were Campylobacter jejuni. No Campylobacter was isolated in culture. Conclusion: According to the results of this study, Campylobacter spp. were detected in healthy rabbits, hamsters, and squirrels. In addition, age, gender and sexual status did not significantly affect Campylobacter infection. Furthermore, rabbits and rodents kept as pets should be considered crucial sources of human zoonotic pathogens. They can be reservoirs of Campylobacter spp. and infect people and other animals by shedding these organisms in their stools.
- 1 October 2025
- Published by Negah Scientific Publisher in Iranian Journal of Veterinary Medicine
- Vol. 19 (4) , 677-684
Open AccessDetection of Campylobacter spp. in Healthy Pet Rabbits and Rodents Using Multiplex Polymerase Chain Reaction
Background: Campylobacter is a common cause of human gastroenteritis. These species can cause diarrhea, hematochezia, meningitis, septicemia and Guillain-Barre syndrome. Objectives: This study aims to determine the prevalence of Campylobacter spp. in healthy pet rabbits, guinea pigs, hamsters and squirrels referred to Small Animal Teaching Hospital, Faculty of Veterinary Medicine, University of Tehran. Food-producing animals are vital sources of infection in humans. While rabbit and guinea pig meat and fur consumption have increased in many countries, little is known about their role as a source of infection. Therefore, the true incidence of Campylobacter infections may be underestimated. Methods: Fecal samples from 92 rabbits, four guinea pigs, two hamsters and two squirrels were acquired and assessed for Campylobacter species by culture and multiplex polymerase chain reaction (PCR). Statistical analysis was performed using the SPSS software, version 26. Chi-square and Fisher’s exact tests were used to analyze qualitative data. Results: Five samples from rabbits, one sample from hamsters, and one sample from squirrels were positive for Campylobacter spp. No Campylobacter spp. were detected in guinea pigs. All the species were Campylobacter jejuni. No Campylobacter was isolated in culture. Conclusion: According to the results of this study, Campylobacter spp. were detected in healthy rabbits, hamsters, and squirrels. In addition, age, gender and sexual status did not significantly affect Campylobacter infection. Furthermore, rabbits and rodents kept as pets should be considered crucial sources of human zoonotic pathogens. They can be reservoirs of Campylobacter spp. and infect people and other animals by shedding these organisms in their stools.
- Open Access
- 29 May 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-15
Evaluation of combined BCG and SARS-CoV-2 vaccination for immune enhancement and lung protection in Syrian hamsters
SARS-CoV-2 (SCV2) has posed significant global challenges, necessitating improved immunization strategies to enhance protection and mitigate disease severity. Combining Bacille Calmette-Guérin (BCG) with SCV2 vaccine shows potential due to BCG’s immunomodulatory properties and ability to induce trained immunity. This study evaluates the efficacy of a combined BCG and SCV2 vaccine regimen in enhancing immune responses, controlling viral load, and reducing lung pathology following a live SCV2 challenge in a Syrian hamster model. In this controlled, randomized study, hamsters were divided into six groups and immunized with various BCG and SCV2 vaccine regimens. Hamsters were randomized into six groups: Group A received a high dose of BCG (5 × 10⁶ CFU) plus SCV2 vaccine on Days 0 and 14; Group B (control) received PBS; Group C received BCG alone; Group D received SCV2 vaccine alone; Group E received a BCG/SCV2 combination on Day 0 and SCV2 booster on Day 14; Group F received a low BCG dose (5 × 10³ CFU) plus SCV2 on both days. Post-challenge, weight changes, lung histopathology, neutralizing antibody titers, and viral load were assessed using qRT-PCR, TCID50, and histological scoring to evaluate immunogenicity, viral control, and tissue damage. Post-challenge, Group A (Combined BCG [5 × 106 CFU] and SCV2 vaccine on Day 0 and Day 14 as a booster) demonstrated stable weights and the strongest neutralizing antibody titers, effectively suppressing viral replication and showing minimal lung pathology (P < 0.05). In contrast, the control group (B) exhibited significant weight loss, high viral loads, and severe lung damage. Groups C, D, E, and F showed varying degrees of immune responses and pathology, with Group F (BCG [5 × 103 CFU]) performing better than others but less effectively than Group A. The present investigation findings highlight the potential of a combined BCG and SCV2 vaccination strategy with an emphasis on dose to provide robust protection against severe COVID-19 outcomes and underscore the role of BCG as an immunological adjuvant to improve vaccine efficacy.
- 29 May 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-15
Open AccessEvaluation of combined BCG and SARS-CoV-2 vaccination for immune enhancement and lung protection in Syrian hamsters
SARS-CoV-2 (SCV2) has posed significant global challenges, necessitating improved immunization strategies to enhance protection and mitigate disease severity. Combining Bacille Calmette-Guérin (BCG) with SCV2 vaccine shows potential due to BCG’s immunomodulatory properties and ability to induce trained immunity. This study evaluates the efficacy of a combined BCG and SCV2 vaccine regimen in enhancing immune responses, controlling viral load, and reducing lung pathology following a live SCV2 challenge in a Syrian hamster model. In this controlled, randomized study, hamsters were divided into six groups and immunized with various BCG and SCV2 vaccine regimens. Hamsters were randomized into six groups: Group A received a high dose of BCG (5 × 10⁶ CFU) plus SCV2 vaccine on Days 0 and 14; Group B (control) received PBS; Group C received BCG alone; Group D received SCV2 vaccine alone; Group E received a BCG/SCV2 combination on Day 0 and SCV2 booster on Day 14; Group F received a low BCG dose (5 × 10³ CFU) plus SCV2 on both days. Post-challenge, weight changes, lung histopathology, neutralizing antibody titers, and viral load were assessed using qRT-PCR, TCID50, and histological scoring to evaluate immunogenicity, viral control, and tissue damage. Post-challenge, Group A (Combined BCG [5 × 106 CFU] and SCV2 vaccine on Day 0 and Day 14 as a booster) demonstrated stable weights and the strongest neutralizing antibody titers, effectively suppressing viral replication and showing minimal lung pathology (P < 0.05). In contrast, the control group (B) exhibited significant weight loss, high viral loads, and severe lung damage. Groups C, D, E, and F showed varying degrees of immune responses and pathology, with Group F (BCG [5 × 103 CFU]) performing better than others but less effectively than Group A. The present investigation findings highlight the potential of a combined BCG and SCV2 vaccination strategy with an emphasis on dose to provide robust protection against severe COVID-19 outcomes and underscore the role of BCG as an immunological adjuvant to improve vaccine efficacy.
- Open Access
- 23 May 2025
- Published by Wiley in Veterinary Medicine and Science
- Vol. 11 (3) , e70407
Evaluating the Antimicrobial and Antibiofilm Efficacy of Lavender Essential Oil and Linalool on Dual Candida albicans Biofilms With Staphylococcus aureus and Staphylococcus epidermidis From Canine External Otitis
Background: Biofilm formation significantly contributes to the rise of antimicrobial resistance, treatment failures and recurrent infections. Essential oils (EOs), particularly lavender EO (LEO), have gained attention for their antimicrobial and antibiofilm activities. This study investigates the effects of LEO and linalool on Staphylococcus aureus ( S. aureus ), Staphylococcus epidermidis ( S. epidermidis ), and Candida albicans ( C. albicans ) isolates. Materials and Methods: The chemical composition of LEO was analysed using gas chromatography‐mass spectrometry (GC‐MS). Eight clinical and reference microorganisms were tested, including four C. albicans , three S. aureus , and three S. epidermidis isolates, to assess their biofilm‐producing potential with the tissue microtiter plate method. Antimicrobial and antibiofilm activities of LEO and linalool were evaluated in planktonic, single‐biofilm, and dual‐biofilm phases through microbroth dilution and scanning electron microscopy (SEM). Results: The minimum inhibitory concentration (MIC) and minimum bactericidal/fungicidal concentration (MBC/MFC) of LEO in the planktonic phase were 1250 µg/mL and 2500 µg/mL against Staphylococcus isolates, respectively, while the corresponding value for C. albicans isolates was 5000 µg/mL. 90% biofilm inhibition was achieved at concentrations of 5000 µg/mL and 40,000 µg/mL for Staphylococcus and C. albicans , respectively. LEO completely inhibited dual biofilms formed by C. albicans / S. aureus and C. albicans / S. epidermidis at 20,000 µg/mL, whereas linalool attained 100% inhibition at 40,000 µg/mL. Conclusion: LEO demonstrates significant antimicrobial and antibiofilm activity against Staphylococcus and C. albicans isolates, effective in both planktonic and biofilm phases.
- 23 May 2025
- Published by Wiley in Veterinary Medicine and Science
- Vol. 11 (3) , e70407
Open AccessEvaluating the Antimicrobial and Antibiofilm Efficacy of Lavender Essential Oil and Linalool on Dual Candida albicans Biofilms With Staphylococcus aureus and Staphylococcus epidermidis From Canine External Otitis
Background: Biofilm formation significantly contributes to the rise of antimicrobial resistance, treatment failures and recurrent infections. Essential oils (EOs), particularly lavender EO (LEO), have gained attention for their antimicrobial and antibiofilm activities. This study investigates the effects of LEO and linalool on Staphylococcus aureus ( S. aureus ), Staphylococcus epidermidis ( S. epidermidis ), and Candida albicans ( C. albicans ) isolates. Materials and Methods: The chemical composition of LEO was analysed using gas chromatography‐mass spectrometry (GC‐MS). Eight clinical and reference microorganisms were tested, including four C. albicans , three S. aureus , and three S. epidermidis isolates, to assess their biofilm‐producing potential with the tissue microtiter plate method. Antimicrobial and antibiofilm activities of LEO and linalool were evaluated in planktonic, single‐biofilm, and dual‐biofilm phases through microbroth dilution and scanning electron microscopy (SEM). Results: The minimum inhibitory concentration (MIC) and minimum bactericidal/fungicidal concentration (MBC/MFC) of LEO in the planktonic phase were 1250 µg/mL and 2500 µg/mL against Staphylococcus isolates, respectively, while the corresponding value for C. albicans isolates was 5000 µg/mL. 90% biofilm inhibition was achieved at concentrations of 5000 µg/mL and 40,000 µg/mL for Staphylococcus and C. albicans , respectively. LEO completely inhibited dual biofilms formed by C. albicans / S. aureus and C. albicans / S. epidermidis at 20,000 µg/mL, whereas linalool attained 100% inhibition at 40,000 µg/mL. Conclusion: LEO demonstrates significant antimicrobial and antibiofilm activity against Staphylococcus and C. albicans isolates, effective in both planktonic and biofilm phases.
- Open Access
- 12 April 2025
- Published by Knowledge E DMCC in Iranian Journal of Microbiology
- Vol. 17 (2) , 312-320
Impact of oleuropein on Candida albicans and Staphylococcus aureus adhesion and its mediated toxicity in Zebrafish (Danio rerio) embryos
Background and Objectives: The rising prevalence of antibiotic resistance and biofilm-associated infections poses signif- icant challenges in clinical settings. This study investigates the antimicrobial and anti-adhesive properties of oleuropein, a compound derived from olive leaves, against Candida albicans and Staphylococcus aureus. Materials and Methods: This study was conducted on Candida albicans (fluconazole-resistant/susceptible) and Staphylo- coccus aureus (methicillin-resistant/susceptible). The antifungal, antibacterial, anti-adhesion, and cell surface hydrophobic- ity (CSH) effects of oleuropein were evaluated. The impact of oleuropein on germ tube formation (GTF) in C. albicans was assessed. Finally, the toxicity of oleuropein was evaluated in zebrafish embryos. Results: Oleuropein exhibited MIC values of 10 mg/ml for C. albicans and 5 mg/ml for S. aureus. It significantly (P< 0.05) reduced the adhesion of both microorganisms in a dose-dependent manner, with inhibition percentages of 78.43% and 75.91% for C. albicans and S. aureus, respectively. Additionally, oleuropein reduced the CSH of C. albicans, indicating its potential to interfere with adhesion mechanisms. In addition, oleuropein exhibited inhibition of GTF in C. albicans. Conclusion: Oleuropein demonstrates significant antimicrobial and anti-adhesive properties against C. albicans and S. au- reus, indicating its potential as a therapeutic agent for preventing biofilm-related infections. However, careful dosage man- agement is crucial due to its observed toxicity at higher concentrations.
- 12 April 2025
- Published by Knowledge E DMCC in Iranian Journal of Microbiology
- Vol. 17 (2) , 312-320
Open AccessImpact of oleuropein on Candida albicans and Staphylococcus aureus adhesion and its mediated toxicity in Zebrafish (Danio rerio) embryos
Background and Objectives: The rising prevalence of antibiotic resistance and biofilm-associated infections poses signif- icant challenges in clinical settings. This study investigates the antimicrobial and anti-adhesive properties of oleuropein, a compound derived from olive leaves, against Candida albicans and Staphylococcus aureus. Materials and Methods: This study was conducted on Candida albicans (fluconazole-resistant/susceptible) and Staphylo- coccus aureus (methicillin-resistant/susceptible). The antifungal, antibacterial, anti-adhesion, and cell surface hydrophobic- ity (CSH) effects of oleuropein were evaluated. The impact of oleuropein on germ tube formation (GTF) in C. albicans was assessed. Finally, the toxicity of oleuropein was evaluated in zebrafish embryos. Results: Oleuropein exhibited MIC values of 10 mg/ml for C. albicans and 5 mg/ml for S. aureus. It significantly (P< 0.05) reduced the adhesion of both microorganisms in a dose-dependent manner, with inhibition percentages of 78.43% and 75.91% for C. albicans and S. aureus, respectively. Additionally, oleuropein reduced the CSH of C. albicans, indicating its potential to interfere with adhesion mechanisms. In addition, oleuropein exhibited inhibition of GTF in C. albicans. Conclusion: Oleuropein demonstrates significant antimicrobial and anti-adhesive properties against C. albicans and S. au- reus, indicating its potential as a therapeutic agent for preventing biofilm-related infections. However, careful dosage man- agement is crucial due to its observed toxicity at higher concentrations.
- Open Access
- 20 February 2025
- Published by Springer Nature in BMC Biotechnology
- Vol. 25 (1) , 1-16
Synergistic antibacterial activity of chitosan-polyethylene glycol nanocomposites films containing ZIF-8 and doxycycline
Antibiotic resistance is a growing global threat due to antibiotic overuse and limited treatment options. Multidrug-resistant bacteria, like Staphylococcus aureus and Escherichia coli, increase infection complexity and mortality. This study explores nanocomposite films of ZIF-8 nanoparticles and Doxycycline (Dox) to enhance antibacterial efficacy. In this study, nanocomposite films composed of chitosan (CS) and polyethylene glycol (PEG), incorporating zeolitic imidazolate framework-8 (ZIF-8) nanoparticles and DOX, were developed. These films were characterized by their morphological, mechanical, antibacterial, and drug-release properties. Antibacterial efficacy was evaluated using disk diffusion, broth microdilution, and checkerboard assay methods to determine MICs and potential synergistic effects. The nanocomposite films demonstrated flexibility, semi-transparency, and a yellowish-brown hue, with films containing ZIF-8 nanoparticles being thicker (79 ± 0.2 μm) than those without (54 ± 0.5 μm). The tensile strength was enhanced with the incorporation of ZIF-8, peaking at 53.12 MPa for the CS-PEG-G-10% DOX-4% ZIF-8 film. XRD analysis confirmed the crystallinity of the ZIF-8 and DOX, with distinct peaks observed for each material. The drug release studies revealed an initial burst followed by sustained release, with higher release rates in acidic environments compared to neutral and alkaline media. The CS-PEG-G-10% DOX-4% ZIF-8 nanocomposite film demonstrated significantly higher antibacterial activity, achieving the lowest MIC values, particularly against S. aureus (22.5 mm inhibition zone) compared to E. coli (14 mm inhibition zone). Additionally, a notable synergistic effect was observed between CS-PEG-G-10% DOX and CS-PEG-G-10% DOX, with FICI values below 0.5. The CS-PEG-G-10% DOX-4% ZIF-8 nanocomposite exhibits enhanced antibacterial efficacy and optimal properties, positioning it as a strong candidate for developing effective treatments against multidrug-resistant pathogens.
- 20 February 2025
- Published by Springer Nature in BMC Biotechnology
- Vol. 25 (1) , 1-16
Open AccessSynergistic antibacterial activity of chitosan-polyethylene glycol nanocomposites films containing ZIF-8 and doxycycline
Antibiotic resistance is a growing global threat due to antibiotic overuse and limited treatment options. Multidrug-resistant bacteria, like Staphylococcus aureus and Escherichia coli, increase infection complexity and mortality. This study explores nanocomposite films of ZIF-8 nanoparticles and Doxycycline (Dox) to enhance antibacterial efficacy. In this study, nanocomposite films composed of chitosan (CS) and polyethylene glycol (PEG), incorporating zeolitic imidazolate framework-8 (ZIF-8) nanoparticles and DOX, were developed. These films were characterized by their morphological, mechanical, antibacterial, and drug-release properties. Antibacterial efficacy was evaluated using disk diffusion, broth microdilution, and checkerboard assay methods to determine MICs and potential synergistic effects. The nanocomposite films demonstrated flexibility, semi-transparency, and a yellowish-brown hue, with films containing ZIF-8 nanoparticles being thicker (79 ± 0.2 μm) than those without (54 ± 0.5 μm). The tensile strength was enhanced with the incorporation of ZIF-8, peaking at 53.12 MPa for the CS-PEG-G-10% DOX-4% ZIF-8 film. XRD analysis confirmed the crystallinity of the ZIF-8 and DOX, with distinct peaks observed for each material. The drug release studies revealed an initial burst followed by sustained release, with higher release rates in acidic environments compared to neutral and alkaline media. The CS-PEG-G-10% DOX-4% ZIF-8 nanocomposite film demonstrated significantly higher antibacterial activity, achieving the lowest MIC values, particularly against S. aureus (22.5 mm inhibition zone) compared to E. coli (14 mm inhibition zone). Additionally, a notable synergistic effect was observed between CS-PEG-G-10% DOX and CS-PEG-G-10% DOX, with FICI values below 0.5. The CS-PEG-G-10% DOX-4% ZIF-8 nanocomposite exhibits enhanced antibacterial efficacy and optimal properties, positioning it as a strong candidate for developing effective treatments against multidrug-resistant pathogens.
- Open Access
- 25 November 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-17
Mesoporous silica nanoparticles co-loaded with lysozyme and vancomycin for synergistic antimicrobial action
Nanotechnology offers a novel strategy for enhancing the susceptibility of pathogens resistant to traditional antibiotics. Another effective strategy is combination therapy, where multiple agents are used together to improve treatment efficacy. In this study, both nanoparticle-based formulation and combinatorial therapy were utilized to develop a potent antibacterial system targeting infectious bacteria. Lysozyme (Lys) and Vancomycin (Van) were co-loaded onto mesoporous silica nanoparticles (MSNs), forming Lys-Van-MSNs. The antimicrobial activity of these nanoparticles was evaluated by determining the minimum inhibitory concentration (MIC) against Staphylococcus aureus. The MIC values for Lys-Van-MSNs were 0.85 µg/ml for Van and 0.168 mg/ml for Lys, reflecting reductions of 86.4% and 93.7%, respectively, compared to the free forms. Additionally, cytotoxicity was tested using MTT, ROS, and hemolysis assays on human cell lines (breast, fibroblast, and AGS), showing over 80% cell viability, indicating minimal toxicity. The MSN-based formulation, with its synergistic antibacterial effects, reduced drug dosage, and high biocompatibility, offers a practical and effective solution for addressing bacterial infections.
- 25 November 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-17
Open AccessMesoporous silica nanoparticles co-loaded with lysozyme and vancomycin for synergistic antimicrobial action
Nanotechnology offers a novel strategy for enhancing the susceptibility of pathogens resistant to traditional antibiotics. Another effective strategy is combination therapy, where multiple agents are used together to improve treatment efficacy. In this study, both nanoparticle-based formulation and combinatorial therapy were utilized to develop a potent antibacterial system targeting infectious bacteria. Lysozyme (Lys) and Vancomycin (Van) were co-loaded onto mesoporous silica nanoparticles (MSNs), forming Lys-Van-MSNs. The antimicrobial activity of these nanoparticles was evaluated by determining the minimum inhibitory concentration (MIC) against Staphylococcus aureus. The MIC values for Lys-Van-MSNs were 0.85 µg/ml for Van and 0.168 mg/ml for Lys, reflecting reductions of 86.4% and 93.7%, respectively, compared to the free forms. Additionally, cytotoxicity was tested using MTT, ROS, and hemolysis assays on human cell lines (breast, fibroblast, and AGS), showing over 80% cell viability, indicating minimal toxicity. The MSN-based formulation, with its synergistic antibacterial effects, reduced drug dosage, and high biocompatibility, offers a practical and effective solution for addressing bacterial infections.
- Open Access
- 1 April 2024
- Published by Springer Nature in BMC Veterinary Research
- Vol. 20 (1) , 1-11
Antibacterial effects of chitosan-based hydrogels containing Trachyspermum ammi essential oil on pathogens isolated from dogs with otitis externa
Growing antibiotic resistance has made treating otitis externa (OE) increasingly challenging. On the other hand, local antimicrobial treatments, especially those that combine essential oils (EOs) with nanoparticles, tend to be preferred over systemic ones. It was investigated whether Ajwain (Trachyspermum ammi) EO, combined with chitosan nanoparticles modified by cholesterol, could inhibit the growth of bacterial pathogens isolated from OE cases in dogs. In total, 57 dogs with clinical signs of OE were examined and bacteriologically tested. Hydrogels of Chitosan were synthesized by self-assembly and investigated. EO was extracted (Clevenger machine), and its ingredients were checked (GC-MS analysis) and encapsulated in chitosan-cholesterol nanoparticles. Disc-diffusion and broth Micro-dilution (MIC and MBC) examined its antimicrobial and therapeutic properties. Staphylococcus pseudintermedius (49.3%) was the most common bacteria isolated from OE cases, followed by Pseudomonas aeruginosa (14.7%), Escherichia coli (13.3%), Streptococcus canis (9.3%), Corynebacterium auriscanis (6.7%), Klebsiella pneumoniae (2.7%), Proteus mirabilis (2.7%), and Bacillus cereus (1.3%). The investigation into the antimicrobial properties of Ajwain EO encapsulated in chitosan nanoparticles revealed that it exhibited a more pronounced antimicrobial effect against the pathogens responsible for OE. Using chitosan nanoparticles encapsulated with EO presents an effective treatment approach for dogs with OE that conventional antimicrobial treatments have not cured. This approach not only enhances antibacterial effects but also reduces the required dosage of antimicrobials, potentially preventing the emergence of antimicrobial resistance.
- 1 April 2024
- Published by Springer Nature in BMC Veterinary Research
- Vol. 20 (1) , 1-11
Open AccessAntibacterial effects of chitosan-based hydrogels containing Trachyspermum ammi essential oil on pathogens isolated from dogs with otitis externa
Growing antibiotic resistance has made treating otitis externa (OE) increasingly challenging. On the other hand, local antimicrobial treatments, especially those that combine essential oils (EOs) with nanoparticles, tend to be preferred over systemic ones. It was investigated whether Ajwain (Trachyspermum ammi) EO, combined with chitosan nanoparticles modified by cholesterol, could inhibit the growth of bacterial pathogens isolated from OE cases in dogs. In total, 57 dogs with clinical signs of OE were examined and bacteriologically tested. Hydrogels of Chitosan were synthesized by self-assembly and investigated. EO was extracted (Clevenger machine), and its ingredients were checked (GC-MS analysis) and encapsulated in chitosan-cholesterol nanoparticles. Disc-diffusion and broth Micro-dilution (MIC and MBC) examined its antimicrobial and therapeutic properties. Staphylococcus pseudintermedius (49.3%) was the most common bacteria isolated from OE cases, followed by Pseudomonas aeruginosa (14.7%), Escherichia coli (13.3%), Streptococcus canis (9.3%), Corynebacterium auriscanis (6.7%), Klebsiella pneumoniae (2.7%), Proteus mirabilis (2.7%), and Bacillus cereus (1.3%). The investigation into the antimicrobial properties of Ajwain EO encapsulated in chitosan nanoparticles revealed that it exhibited a more pronounced antimicrobial effect against the pathogens responsible for OE. Using chitosan nanoparticles encapsulated with EO presents an effective treatment approach for dogs with OE that conventional antimicrobial treatments have not cured. This approach not only enhances antibacterial effects but also reduces the required dosage of antimicrobials, potentially preventing the emergence of antimicrobial resistance.
- 5 February 2024
- Published by Wiley in Equine Veterinary Education
- Vol. 37 (1) , 29-35
Investigation of healthy horse eyes microbiota and evaluation of its antimicrobial susceptibility
Summary: Background: The conjunctiva of the eye is a mucosal surface that is colonised by various bacteria. Following surgery, trauma or other underlying conditions the normal flora may cause eye infection such as conjunctival and corneal infections, or endophthalmitis. Objectives: This study aimed to investigate the bacterial population and antibiotic resistance of the conjunctiva in healthy horses. Study design: Random sampling of ocular samples from 20 horses during the winter (2019). Methods: Swab samples were collected from the eyes of 20 healthy horses of different breeds, ages and sexes in Tehran province, Iran. The swabs were cultured on blood agar and MacConkey agar and incubated at 37°C for 24–48 h. The isolated bacteria were characterised using cellular morphology, gram‐staining and biochemical tests. Sensitivity and resistance to 10 different antibiotics were measured using an antibiogram test. Results: Results showed that the bacterial population consisted of various species, with Bacillus cereus being the most frequent. There were no significant differences in the frequency of isolated bacteria between sexes and age groups. There were no significant differences in the sensitivity of the bacterial flora of the eyes to colistin, ceftiofur, florfenicol, amoxicillin and ampicillin between either different age groups or different sexes of the horses ( p > 0.05). However, sensitivity to enrofloxacin and ciprofloxacin was significantly correlated with the age groups of the horses ( p > 0.05). A significant difference in sensitivity to trimethoprim‐sulfamethoxazole between various sexes of horses was observed. Main limitations: The nonuniformity of the follow‐up examination, reliance on owners or caregivers of the horse for follow‐up information and lack of adequate financial resources to study more horses. Conclusions: The study suggests that the frequency of individual bacteria comprising the bacterial flora in horses' eyes is influenced by housing and management conditions rather than age and sex.
- 5 February 2024
- Published by Wiley in Equine Veterinary Education
- Vol. 37 (1) , 29-35
Investigation of healthy horse eyes microbiota and evaluation of its antimicrobial susceptibility
Summary: Background: The conjunctiva of the eye is a mucosal surface that is colonised by various bacteria. Following surgery, trauma or other underlying conditions the normal flora may cause eye infection such as conjunctival and corneal infections, or endophthalmitis. Objectives: This study aimed to investigate the bacterial population and antibiotic resistance of the conjunctiva in healthy horses. Study design: Random sampling of ocular samples from 20 horses during the winter (2019). Methods: Swab samples were collected from the eyes of 20 healthy horses of different breeds, ages and sexes in Tehran province, Iran. The swabs were cultured on blood agar and MacConkey agar and incubated at 37°C for 24–48 h. The isolated bacteria were characterised using cellular morphology, gram‐staining and biochemical tests. Sensitivity and resistance to 10 different antibiotics were measured using an antibiogram test. Results: Results showed that the bacterial population consisted of various species, with Bacillus cereus being the most frequent. There were no significant differences in the frequency of isolated bacteria between sexes and age groups. There were no significant differences in the sensitivity of the bacterial flora of the eyes to colistin, ceftiofur, florfenicol, amoxicillin and ampicillin between either different age groups or different sexes of the horses ( p > 0.05). However, sensitivity to enrofloxacin and ciprofloxacin was significantly correlated with the age groups of the horses ( p > 0.05). A significant difference in sensitivity to trimethoprim‐sulfamethoxazole between various sexes of horses was observed. Main limitations: The nonuniformity of the follow‐up examination, reliance on owners or caregivers of the horse for follow‐up information and lack of adequate financial resources to study more horses. Conclusions: The study suggests that the frequency of individual bacteria comprising the bacterial flora in horses' eyes is influenced by housing and management conditions rather than age and sex.